A Human Fatty Acid Amide Hydrolase (FAAH) Functional Gene Variant Is Associated With Lower Blood Pressure in Young Males
Author(s) -
Riccardo Sarzani,
Marica Bordicchia,
Fabio Salvi,
Giovanna Cola,
Elena Franchi,
Ilaria Battistoni,
Lucia Mancinelli,
A Giovagnoli,
Paolo DessìFulgheri,
A Rappelli
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2008.198
Subject(s) - fatty acid amide hydrolase , medicine , blood pressure , endocrinology , allele , endocannabinoid system , genotype , antagonist , genetics , receptor , cannabinoid receptor , gene , biology
Fatty acid amide hydrolase (FAAH) inhibitors, preventing endocannabinoid (EC) degradation, reduce blood pressure (BP) and heart rate in young male (YM) hypertensive rodents. The functional human FAAH 129T gene variant results in reduced protein level and enzymatic activity but its relationship with BP is unknown. This study investigates the relationship among FAAH P129T alleles and cardiovascular features in YMs at baseline and after 9-year follow-up, and in older male obese hypertensive (OH) patients, in whom the EC system (ECS) is overactive.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom